Clinical Trial Update: Use of Liquid Stable Levothyroxine in Trisomy 21 Pediatric Patients [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating liquid stable levothyroxine in pediatric patients with hypothyroidism and Trisomy 21 has been terminated with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypothyroidism
• Trisomy 21

Drugs mentioned

• levothyroxine (liquid stable formulation) (levothyroxine)

Snippet

Sponsor: Children's Mercy Hospital Kansas City | Conditions: Hypothyroidism, Trisomy 21 | Phase 4 | Status: TERMINATED | Results posted: 2023-04-10